Regulation 3

P is the holder of a pharmacy licence;

the supply of the specified health product is carried out at or from the retail pharmacy specified in the pharmacy licence —

by an in-store pharmaceutical officer; or

in the absence of that officer, by a special mode with the prior approval of the Authority;

the supply of the specified health product is carried out under, and in accordance with the conditions of, the pharmacy licence;

a proper record of every supply of the specified health product is made by the in-store pharmaceutical officer mentioned in sub-paragraph (b)(i), or using that special mode of supply mentioned in sub-paragraph (b)(ii);

P keeps the record made under sub-paragraph (d) for at least 2 years after the date of the supply of the specified health product to which the record relates;

P ensures that only an in-store pharmaceutical officer may have access to specified health products (other than a controlled drug) stored at the retail pharmacy; and

P ensures that only a qualified pharmacist may have access to any controlled drug stored at the retail pharmacy.

the prescription-only medicine is supplied —

to a patient in accordance with a valid prescription given by a qualified practitioner or collaborative prescribing practitioner; or

in accordance with the oral or written instructions of a qualified practitioner or collaborative prescribing practitioner who undertakes, when giving the instructions, to give a valid prescription within 24 hours after giving the instructions; or

in the case of therapeutic products only, the prescription-only medicine supplied —

is specified in the list of prescription-only medicines exempted for limited sale and supply;

is labelled to show a maximum daily dose not exceeding that specified in the list of prescription‑only medicines exempted for limited sale and supply;

does not exceed the maximum supply specified in the list of prescription-only medicines exempted for limited sale and supply;

is to a person who is of or above any minimum age specified in the list of prescription-only medicines exempted for limited sale and supply, and a record of the supply is made in accordance with regulation 16 of the Health Products (Therapeutic Products) Regulations 2016 (G.N. No. S 329/2016).

[Deleted by S 808/2023 wef 18/12/2023](aa)any of the following persons who supplies a specified health product by retail sale to a patient of a healthcare service licensee in accordance with the written instructions of a qualified practitioner or collaborative prescribing practitioner, who is a personnel of the healthcare service licensee:

the healthcare service licensee;

a person who is authorised by the healthcare service licensee to make that supply; or

a qualified practitioner or collaborative prescribing practitioner, or a person acting in accordance with the oral or written instructions of a qualified practitioner or collaborative prescribing practitioner, supplying a specified health product to a patient under the care of the qualified practitioner or collaborative prescribing practitioner.

the supply by retail sale of influenza vaccines in accordance with the conditions of such supply specified in item 2A of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016; or

the supply by retail sale of adrenaline administered using an autoinjector in accordance with the conditions of such supply specified in item 2B of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016.

be made in the form and manner specified on the Authority’s website; and

be accompanied by the application fee.